Patent ID: 11903965
Assignee: HDL THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A

Claim 0:
1. A method for preserving pre-beta high density lipoprotein for administration to a patient, comprising:
obtaining a batch of delipidated plasma comprising the pre-beta high density lipoprotein;
testing a portion of the batch of the delipidated plasma to determine a first concentration of the pre-beta high density lipoprotein in the delipidated plasma;
preserving the batch of the delipidated plasma;
after a period of time, preparing the preserved delipidated plasma for administration to the patient, wherein the period of time ranges from one week to three years;
testing a portion of the prepared preserved delipidated plasma by acquiring a first amount of the preserved delipidated plasma, determining an amount of pre-beta high density lipoprotein in the preserved delipidated plasma using gel testing, determining if the first concentration of the pre-beta high density lipoprotein has decreased below an acceptable threshold level, wherein, if the first concentration has decreased below an acceptable threshold level, concluding that the prepared preserved delipidated plasma is not suitable for administration and wherein, if the first concentration is at or above the acceptable threshold level, concluding that the prepared preserved delipidated plasma is suitable for administration; and
based on concluding that the prepared preserved delipidated plasma is suitable for administration, administering the prepared preserved delipidated plasma to the patient.